{"id":"https://openalex.org/W2094064004","doi":"https://doi.org/10.1300/j069v20n02_06","title":"Buprenorphine Treatment of Heroin Dependence (Detoxification and Maintenance) in a Private Practice Setting","display_name":"Buprenorphine Treatment of Heroin Dependence (Detoxification and Maintenance) in a Private Practice Setting","publication_year":2001,"publication_date":"2001-04-02","ids":{"openalex":"https://openalex.org/W2094064004","doi":"https://doi.org/10.1300/j069v20n02_06","mag":"2094064004","pmid":"https://pubmed.ncbi.nlm.nih.gov/11318399"},"language":"en","primary_location":{"id":"doi:10.1300/j069v20n02_06","doi":"https://doi.org/10.1300/j069v20n02_06","is_oa":false,"landing_page_url":"https://doi.org/10.1300/j069v20n02_06","pdf_url":null,"source":{"id":"https://openalex.org/S93508928","display_name":"Journal of Addictive Diseases","issn_l":"1055-0887","issn":["1055-0887","1545-0848"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Addictive Diseases","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112137665","display_name":"Richard B. Resnick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Richard B. Resnick","raw_affiliation_strings":["New York University Medical Center, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York University Medical Center, USA","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042048224","display_name":"Marc S. Galanter","orcid":"https://orcid.org/0000-0002-1978-4453","observed_orcids":["https://orcid.org/0000-0002-1978-4453"]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marc Galanter","raw_affiliation_strings":["New York University Medical Center, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York University Medical Center, USA","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065717428","display_name":"Elaine Resnick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Elaine Resnick","raw_affiliation_strings":["(Center for Psychiatry & Family Therapy) , New York University Medical Center , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"(Center for Psychiatry & Family Therapy) , New York University Medical Center , USA","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5065580714","display_name":"Colette Pycha","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086933","display_name":"NYU Langone Health","ror":"https://ror.org/005dvqh91","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210086933"]},{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Colette Pycha","raw_affiliation_strings":["New York University Medical Center, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York University Medical Center, USA","institution_ids":["https://openalex.org/I4210086933","https://openalex.org/I57206974"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":4.0451,"has_fulltext":false,"cited_by_count":20,"citation_normalized_percentile":{"value":0.9335015,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":null,"biblio":{"volume":"20","issue":"2","first_page":"75","last_page":"83"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10576","display_name":"Opioid Use Disorder Treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11199","display_name":"Pain Management and Opioid Use","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2703","display_name":"Anesthesiology and Pain Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/buprenorphine","display_name":"buprenorphine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/heroin-dependence","display_name":"heroin addiction","score":0.9959999918937683},{"id":"https://openalex.org/keywords/opioid-detoxification","display_name":"opioid detoxification","score":0.8450000286102295},{"id":"https://openalex.org/keywords/opioid-maintenance-treatment","display_name":"opioid maintenance treatment","score":0.7009999752044678},{"id":"https://openalex.org/keywords/office-based-treatment","display_name":"office-based treatment","score":0.75},{"id":"https://openalex.org/keywords/fee-for-service","display_name":"fee-for-service","score":0.6790000200271606},{"id":"https://openalex.org/keywords/private-practice","display_name":"private practice","score":0.7509999871253967},{"id":"https://openalex.org/keywords/treatment-refusal","display_name":"treatment refusal","score":0.5329999923706055},{"id":"https://openalex.org/keywords/feasibility","display_name":"feasibility","score":0.5569999814033508},{"id":"https://openalex.org/keywords/underserved-populations","display_name":"underserved populations","score":0.7110000252723694}],"concepts":[{"id":"https://openalex.org/C2778949969","wikidata":"https://www.wikidata.org/wiki/Q407721","display_name":"Buprenorphine","level":4,"score":0.8983467817306519},{"id":"https://openalex.org/C2778903686","wikidata":"https://www.wikidata.org/wiki/Q60168","display_name":"Heroin","level":3,"score":0.701548159122467},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6662741899490356},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.6046091318130493},{"id":"https://openalex.org/C2780497538","wikidata":"https://www.wikidata.org/wiki/Q1192006","display_name":"Detoxification (alternative medicine)","level":3,"score":0.599811851978302},{"id":"https://openalex.org/C2778767360","wikidata":"https://www.wikidata.org/wiki/Q179996","display_name":"Methadone","level":2,"score":0.49732568860054016},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.49605974555015564},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.36933577060699463},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.33404844999313354},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.23319777846336365},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.21449998021125793},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.1818237602710724},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.12021830677986145},{"id":"https://openalex.org/C2781063702","wikidata":"https://www.wikidata.org/wiki/Q427523","display_name":"Opioid","level":3,"score":0.10974285006523132},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002047","descriptor_name":"Buprenorphine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006556","descriptor_name":"Heroin Dependence","qualifier_ui":"Q000534","qualifier_name":"rehabilitation","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008658","descriptor_name":"Inactivation, Metabolic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009294","descriptor_name":"Narcotics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011331","descriptor_name":"Private Practice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1300/j069v20n02_06","doi":"https://doi.org/10.1300/j069v20n02_06","is_oa":false,"landing_page_url":"https://doi.org/10.1300/j069v20n02_06","pdf_url":null,"source":{"id":"https://openalex.org/S93508928","display_name":"Journal of Addictive Diseases","issn_l":"1055-0887","issn":["1055-0887","1545-0848"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Addictive Diseases","raw_type":"journal-article"},{"id":"pmid:11318399","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11318399","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of addictive diseases","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9476000070571899,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":7,"referenced_works":["https://openalex.org/W149383430","https://openalex.org/W1979184030","https://openalex.org/W1980315117","https://openalex.org/W2002091306","https://openalex.org/W2012699801","https://openalex.org/W2040957323","https://openalex.org/W2090987624"],"related_works":["https://openalex.org/W1996055083","https://openalex.org/W2334237091","https://openalex.org/W2000393144","https://openalex.org/W1994254530","https://openalex.org/W2121315752","https://openalex.org/W149383430","https://openalex.org/W2012417875","https://openalex.org/W1530005927","https://openalex.org/W2087259361","https://openalex.org/W2414520113"],"abstract_inverted_index":{"At":[0],"the":[1,45,122],"conclusion":[2],"of":[3,47,58,79,94,115,128],"a":[4,9,39,75,88,102],"3-year":[5],"demonstration":[6],"project":[7],"in":[8,12,33,38,83,101,134,144],"medical":[10],"setting":[11,86],"which":[13],"refusal":[14,35],"to":[15,26,36,43,54,137],"accept":[16],"methadone":[17],"was":[18],"an":[19,65,84],"inclusion":[20],"criterion,":[21],"12":[22,62,76],"subjects":[23,63,68,98],"were":[24,72,99],"unable":[25],"detoxify":[27],"from":[28],"buprenorphine":[29,80,119],"and":[30,112,131],"remained":[31],"adamant":[32],"their":[34],"enroll":[37],"MMTP.":[40],"In":[41],"order":[42],"study":[44],"feasibility":[46,111],"expanding":[48],"opportunities":[49],"for":[50,74,104,124],"treatment":[51,81,140],"previously":[52],"unavailable":[53],"this":[55,129],"under-served":[56],"population":[57,130],"heroin":[59,96],"addicts,":[60],"these":[61],"plus":[64],"additional":[66,92,126],"11":[67],"(N":[69],"=":[70],"23)":[71],"recruited":[73],"months":[77],"trial":[78],"conducted":[82],"office-based":[85],"on":[87],"fee-for-service":[89,118],"basis.":[90],"An":[91],"cohort":[93],"40":[95],"dependent":[97],"entered":[100],"protocol":[103],"detoxification":[105],"only.":[106],"The":[107],"findings":[108],"demonstrate":[109],"both":[110],"patient":[113],"acceptance":[114],"office":[116],"based":[117],"treatment,":[120],"supporting":[121],"need":[123],"(1)":[125],"studies":[127],"(2)":[132],"changes":[133],"government":[135],"regulations":[136],"reintroduce":[138],"addiction":[139],"under":[141],"physician":[142],"auspices":[143],"private":[145],"practice":[146],"settings.":[147]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}